FFCP PHASE1:Hg19::chr20:50158915..50158926,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=4773 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=7776 | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=331bp_to_uc010zyv.1,uc010zyw.1_5end | |||
|cluster_id=chr20:50158915..50158926,- | |||
|coexpression_cluster_id=C8 | |||
|description=CAGE_peak_8_at_NFATC2_5end | |||
|id=chr20:50158915..50158926,- | |||
|ontology_enrichment_celltype=CL:0000738!9.03e-29!140;CL:0000037!1.72e-24!172;CL:0000566!1.72e-24!172;CL:0000988!7.04e-23!182;CL:0000838!2.71e-22!52;CL:0000542!8.07e-22!53;CL:0000051!8.07e-22!53;CL:0000623!2.54e-21!3;CL:0000825!2.54e-21!3;CL:0002031!4.66e-21!124;CL:0002274!2.99e-20!5;CL:0000457!2.99e-20!5;CL:0002191!2.99e-20!5;CL:0000097!2.99e-20!5;CL:0000831!2.99e-20!5;CL:0002028!2.99e-20!5;CL:0002032!4.49e-18!165;CL:0000837!4.49e-18!165;CL:0000624!8.28e-18!6;CL:0000791!2.45e-17!18;CL:0000789!2.45e-17!18;CL:0002420!2.45e-17!18;CL:0002419!2.45e-17!18;CL:0000790!2.45e-17!18;CL:0002087!5.45e-16!119;CL:0000084!3.05e-12!25;CL:0000827!3.05e-12!25;CL:0000163!2.40e-11!9;CL:0000767!2.30e-09!3;CL:0000842!2.41e-09!3;CL:0000134!3.92e-09!358;CL:0002320!7.40e-09!365;CL:0000219!6.96e-08!390;CL:0000810!1.04e-07!1;CL:0000895!1.04e-07!1;CL:0002436!1.04e-07!1;CL:0002427!1.04e-07!1;CL:0002428!1.04e-07!1;CL:0002429!1.04e-07!1;CL:0002433!1.04e-07!1;CL:0002431!1.04e-07!1;CL:0002432!1.04e-07!1;CL:0001024!1.64e-07!1;CL:0000224!3.23e-07!4;CL:0000034!3.98e-07!444;CL:0002393!4.06e-07!9;CL:0002397!4.06e-07!9 | |||
|ontology_enrichment_celltype_v019=CL:0000623;8.34e-35;3!CL:0000791;6.57e-22;18!CL:0000789;6.57e-22;18!CL:0002419;6.57e-22;18!CL:0000624;4.13e-17;6!CL:0002393;6.42e-17;6!CL:0002397;6.42e-17;6!CL:0000542;1.74e-16;53!CL:0000084;1.09e-15;25!CL:0000625;7.74e-10;11!CL:0002087;2.09e-08;104!CL:0000236;3.03e-08;13!CL:0001014;9.53e-07;2!CL:0001016;9.53e-07;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000623,7.88e-35,3;CL:0000825,7.88e-35,3;CL:0000838,3.06e-29,52;CL:0000542,1.17e-28,53;CL:0000051,1.17e-28,53;CL:0002087,2.30e-22,115;CL:0000791,6.23e-22,18;CL:0000789,6.23e-22,18;CL:0002420,6.23e-22,18;CL:0002419,6.23e-22,18;CL:0000790,6.23e-22,18;CL:0002031,2.22e-21,120;CL:0000738,3.26e-21,136;CL:0000624,3.50e-17,6;CL:0000037,8.67e-17,168;CL:0000988,7.91e-16,177;CL:0000084,1.05e-15,25;CL:0000827,1.05e-15,25;CL:0002032,1.96e-15,161;CL:0000837,1.96e-15,161;CL:0002393,1.63e-11,9;CL:0002397,1.63e-11,9;CL:0000625,8.10e-10,11;CL:0000236,1.11e-07,14;CL:0000134,9.17e-07,354;CL:0001014,9.54e-07,2;CL:0001016,9.54e-07,2 | |||
|ontology_enrichment_development_v019=CL:0000790;6.57e-22;18!CL:0000051;1.74e-16;53 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002384!1.76e-08!375 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.786728553697808,0,0.309632246632152,0,0,0,0,0,0.293600439334847,1.10799081706375,1.80490002723128,1.73608696572681,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.84606484554724,1.17447437874188,2.6759125968766,0,1.68152568894461,0,1.96709770113833,3.14408610199332,1.43921049299656,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.766440987203842,0.34362744548263,0,0,0,0,0,0,0,0,0,2.41928091869679,5.34880391567015,4.19990771260117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.371457501329565,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.790204397959275,0,0,0,0,0,0,0,0,0,0,0,0.088048434013226,0.621984346622316,0.432359860250884,0.6312121671319,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.53170748464433,7.97822026980214,7.82892521306465,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.07857100409308,0.106727557803444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.5476039091159,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.121792598380896,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p8@NFATC2 | |||
}} |
Latest revision as of 23:25, 16 September 2015
Short description: | p8@NFATC2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_8_at_NFATC2_5end |
Coexpression cluster: | C8_Natural_CD8_Basophils_CD4_CD14_Peripheral_CD34 |
Association with transcript: | 331bp_to_uc010zyv.1, uc010zyw.1_5end |
EntrezGene: | NFATC2 |
HGNC: | 7776 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
natural killer cell | 7.88e-35 | 3 |
pro-NK cell | 7.88e-35 | 3 |
lymphoid lineage restricted progenitor cell | 3.06e-29 | 52 |
lymphocyte | 1.17e-28 | 53 |
common lymphoid progenitor | 1.17e-28 | 53 |
nongranular leukocyte | 2.30e-22 | 115 |
mature alpha-beta T cell | 6.23e-22 | 18 |
alpha-beta T cell | 6.23e-22 | 18 |
immature T cell | 6.23e-22 | 18 |
mature T cell | 6.23e-22 | 18 |
immature alpha-beta T cell | 6.23e-22 | 18 |
hematopoietic lineage restricted progenitor cell | 2.22e-21 | 120 |
leukocyte | 3.26e-21 | 136 |
CD4-positive, alpha-beta T cell | 3.50e-17 | 6 |
hematopoietic stem cell | 8.67e-17 | 168 |
hematopoietic cell | 7.91e-16 | 177 |
T cell | 1.05e-15 | 25 |
pro-T cell | 1.05e-15 | 25 |
hematopoietic oligopotent progenitor cell | 1.96e-15 | 161 |
hematopoietic multipotent progenitor cell | 1.96e-15 | 161 |
intermediate monocyte | 1.63e-11 | 9 |
CD14-positive, CD16-positive monocyte | 1.63e-11 | 9 |
CD8-positive, alpha-beta T cell | 8.10e-10 | 11 |
B cell | 1.11e-07 | 14 |
mesenchymal cell | 9.17e-07 | 354 |
CD1a-positive Langerhans cell | 9.54e-07 | 2 |
immature CD1a-positive Langerhans cell | 9.54e-07 | 2 |